PRIMARY BILIARY CHOLANGITIS
Clinical trials for PRIMARY BILIARY CHOLANGITIS explained in plain language.
Never miss a new study
Get alerted when new PRIMARY BILIARY CHOLANGITIS trials appear
Sign up with your email to follow new studies for PRIMARY BILIARY CHOLANGITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for rare liver disease
Disease control CompletedThis study tested whether adding the drug bezafibrate to another drug, obeticholic acid, helps people with primary biliary cholangitis (PBC), a chronic liver disease. 72 adults with PBC took one or both drugs for 12 weeks. The main goal was to see if the combination improved live…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Phase: PHASE2 • Sponsor: Intercept Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 03:27 UTC
-
New hope for rare liver disease: drug shows promise in trial
Disease control CompletedThis study tested a drug called saroglitazar magnesium in 196 adults with primary biliary cholangitis (PBC), a chronic liver disease. Participants took either 1 mg or 2 mg of the drug or a placebo daily for up to 12 months. The goal was to see if the drug could improve liver func…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Phase: PHASE2, PHASE3 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control
Last updated May 08, 2026 12:02 UTC
-
New hope for liver disease patients unresponsive to standard drugs
Disease control CompletedThis study tested a new medicine called CNP-104 in 42 adults aged 18-75 with primary biliary cholangitis, a chronic liver disease. Participants were not helped enough by standard treatments. The goal was to check if CNP-104 is safe and can control the disease. The study lasted ab…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Phase: PHASE1, PHASE2 • Sponsor: COUR Pharmaceutical Development Company, Inc. • Aim: Disease control
Last updated Apr 26, 2026 19:38 UTC
-
Online Mind-Body program shows promise for easing anxiety in chronic illness
Symptom relief CompletedThis study tested a 12-week online program that combines gentle movement, breathing exercises, and coping skills for adults with chronic conditions like heart failure, liver disease, or cancer. The goal was to see if it could reduce anxiety and depression. Over 800 people took pa…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Phase: NA • Sponsor: University of Alberta • Aim: Symptom relief
Last updated May 13, 2026 16:03 UTC
-
New wearable device tracks itching and sleep in rare liver disease
Knowledge-focused CompletedThis study tested a wearable sensor (ADAM) to objectively measure scratching and sleep patterns in 30 adults with primary biliary cholangitis (PBC), a rare liver disease that causes intense itching and sleep problems. Participants wore the sensor for 7 nights over four 7-day peri…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Sponsor: Ipsen • Aim: Knowledge-focused
Last updated May 17, 2026 03:29 UTC